Acute hyperkalemia as a complication of intravenous therapy with epsilon-aminocaproic acid

Arna Banerjee; Cristina Stoica; Ann Walia

doi:10.1016/j.jclinane.2010.12.024

Acute hyperkalemia as a complication of intravenous therapy with epsilon-aminocaproic acid

J Clin Anesth. 2011 Nov;23(7):565-8. doi: 10.1016/j.jclinane.2010.12.024.

Authors

Arna Banerjee¹, Cristina Stoica, Ann Walia

Affiliation

¹ Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. arna.banerjee@vanderbilt.edu

PMID: 22050802
DOI: 10.1016/j.jclinane.2010.12.024

Abstract

Epsilon-aminocaproic acid (EACA) is used frequently during surgery as prophylaxis to decrease blood loss and transfusion requirements. A rare complication of EACA induced acute hyperkalemia in a patient undergoing total hip replacement is presented.

Published by Elsevier Inc.

Publication types

Case Reports
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Acute Disease
Aminocaproic Acid / adverse effects*
Aminocaproic Acid / therapeutic use
Antifibrinolytic Agents / adverse effects*
Antifibrinolytic Agents / therapeutic use
Arthroplasty, Replacement, Hip / methods
Blood Loss, Surgical / prevention & control
Female
Humans
Hyperkalemia / chemically induced*
Infusions, Intravenous
Middle Aged

Substances

Antifibrinolytic Agents
Aminocaproic Acid